HVL Pharma UK Ltd
Registered name: HVL PHARMA UK LTD
Part of Haverhill UK Holdco Limited groupHVL Pharma UK Ltd made £32.7m revenue and a £6.5m loss in the year to 30 Dec 2024.
HVL Pharma UK Ltd’s revenue fell 36% to £32.7m in the year to 30 Dec 2024, with a loss of £6.5m and 189 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Haverhill; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Haverhill
- Age
- 45 yrs · since 1981
- Type
- Private Limited Company
Key figures
Financial history
| Year to | 31 Dec 2022 | 30 Dec 2023 | 31 Dec 2023 | 30 Dec 2024 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £57.6m | £50.7m | £50.7m | £32.7m |
| Cost of sales | −£44.5m | −£42.1m | −£42.1m | −£33.8m |
| Gross profit | £13.1m | £8.6m | £8.6m | −£1.1m |
| Operating profit | £8.3m | −£45.5m | −£45.5m | −£5.9m |
| Profit before tax | £8.1m | −£45.7m | −£45.7m | −£6.3m |
| Profit after tax | £8m | −£40m | −£40m | −£6.5m |
| Profit (best available) | £8m | −£40m | −£40m | −£6.5m |
| Employees (average) | 252 | 237 | 237 | 189 |
| Ratios | ||||
| Profit margin | 14% | −78.9% | −78.9% | −19.8% |
| Gross margin | 22.8% | 17% | 17% | −3.4% |
| Revenue per employee | £228k | £214k | £214k | £173k |
| Profit per employee | £31.9k | −£169k | −£169k | −£34.3k |
| Growth (year on year) | ||||
| Revenue growth | — | ▼11.9% | — | ▼35.6% |
| Profit growth | — | ▼598.1% | — | — |
| Headcount growth | — | ▼5.9% | — | ▼20.3% |
| Balance sheet — indirect signals, not revenue | ||||
| Net assets | — | — | — | — |
| Source | Accounts · bulk data Jan 2025 | Accounts · bulk data Oct 2025 | Accounts · bulk data Jan 2025 | Accounts · bulk data Oct 2025 |
How the business works
- Profit margin
- −19.8%
- Profit ÷ revenue.
- Gross margin
- −3.4%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £173k
- Revenue ÷ average employees.
- Profit per employee
- −£34.3k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▼20%
- Now 189
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Haverhill UK Holdco Limitedultimate parent75–100%
- HVL Pharma UK Ltdthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (1)
- Notts Pharma UK LtdRev. £16.3m · Profit −£4.7m
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 30 Dec 2024 (profit −£6.5m), from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.
Updated from Companies House on 20 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.